Preprint
Article

This version is not peer-reviewed.

Development of Human Serum Albumin-Based Hydrogels for Potential Use as Wound Dressings

Submitted:

11 December 2025

Posted:

12 December 2025

You are already at the latest version

Abstract
Protein-based materials such as human serum albumin (HSA) have demonstrated significant potential for the development of novel wound management materials. For the first time, the formation of HSA-based hydrogels was proposed using a combination of ther-mal- and ethanol-induced approaches. The combination of phosphate-buffered saline and limited (up to 20% v/v) ethanol content offers a promising strategy for fabricating human serum albumin-based hydrogels with tunable properties. The hydrogel formation was studied using in situ DLS for qualitative and semi-quantitative analysis of the patterns of protein hydrogel formation through thermally induced gelation. The rheological proper-ties of human serum albumin-based hydrogels were investigated. Hydrogels synthesized via thermally induced gelation using a denaturing agent exhibit a dynamic viscosity ranging from 100 to 10,000 mPa·s. These human serum albumin-based hydrogels repre-sent a promising platform for developing topical therapeutic agents for wound manage-ment and tissue engineering applications. This study investigated the kinetics of tetracy-cline release from human serum albumin-based hydrogels in phosphate-buffered saline (PBS) and fetal bovine serum (FBS). All tested formulations of human serum albumin (HSA)-based hydrogels loaded with tetracycline (0.15 mg/mL) was demonstrated antibacterial activity of against Staphylococcus aureus strains.
Keywords: 
;  ;  ;  ;  

1. Introduction

The skin, the biggest organ in the human body, acts as a critical barrier that maintains homeostasis and protects internal systems from adverse environmental factors [1], while constant exposure to external threats renders it susceptible to various wound injuries [2]. Moreover, wound healing is a multifaceted process involving multiple stages, each requiring stage-specific therapeutic strategies, particularly in the case of chronic wounds [3]. Conventional wound dressings, such as gauze, cotton wool, and bandages, while providing protection against external contaminants, fail to establish optimal moist wound healing conditions, which is crucial for the initial stages of tissue regeneration [4]. Moreover, their drying and subsequent removal cause mechanical re-injury to the wound bed, thereby inducing patient discomfort and significantly impeding the re-epithelialization process [5]. Furthermore, conventional dressings lack targeted therapeutic effects and exhibit inherent functional limitations, substantially restricting their efficacy in the management of complex wounds.
Of particular promise for wound management are protein-based hydrogels and their derivatives [6], which offer significant advantages, including flexibility, high hygroscopicity, and the ability to adapt to varying environmental conditions (e.g., temperature, pH, enzyme presence). These properties contribute to their efficacy across all stages of the wound healing process [7]. A critical property of protein-based hydrogels is their tunable functionality — the ability to dynamically modulate their properties in response to wound microenvironment changes, thereby accelerating or decelerating specific healing phases. Furthermore, they serve as scaffolds that facilitate cellular migration, proliferation, and tissue regeneration [8]. Making biocompatible and biodegradable hydrogels from natural proteins, such as fibrillar (e.g., collagen, elastin, silk fibroin) and globular (e.g., albumin) types, represents a promising research direction due to their wide availability and well-characterized properties. [9]. Hydrogels derived from collagen, elastin, and silk fibroin, which are widely used in wound management and regenerative medicine, exhibit high affinity for epithelial tissues, hydrophilicity, biocompatibility, and biodegradability. However, their broad adoption is hindered by suboptimal mechanical properties, as well as the complexity and high cost of purification processes [10]. Globular proteins are capable of forming hydrogels under specific pH or temperature conditions or in the presence of cross-linking agents. These hydrogels exhibit exceptional mechanical strength, stability, and tunability, making them promising materials for applications in biotechnology and medicine [11].
One of the most prominent examples of globular proteins in biomedicine are bovine serum albumin (BSA) and human serum albumin (HSA), which demonstrate exceptional biological functionalities. These include promoting angiogenesis, enhancing capillary permeability, facilitating wound healing, and supporting bone regeneration [10]. In recent years, there has been growing interest in the use of BSA- and HSA-based hydrogels for the treatment of wounds of various etiologies. However, current research in this area predominantly involves composite systems combining these proteins with carbohydrates or synthetic polymers [11,12,13,14,15]. These hydrogels need labor-intensive fabrication processes, necessitating the development of alternative approaches enabling the production of albumin-based hydrogels with enhanced simplicity and versatility.
There are four principal methodologies for fabricating albumin-based hydrogels: pH-induced gelation, thermally induced assembly, chemically cross-linking agents, and the application of hydrophobic interaction-modifying agents for protein macromolecules [16,17,18]. Thermally induced gelation represents a versatile, rapid, and convenient method for fabricating albumin-based hydrogels while eliminating the need for toxic and/or costly cross-linking agents [19]. Nevertheless, the majority of studies on thermally induced albumin hydrogel formation have been conducted using bovine serum albumin (BSA), despite the fact that BSA and human serum albumin (HSA) share only 76% amino acid sequence homology [20]. This substantial divergence in primary structure results in significant functional differences between the two proteins. Consequently, data obtained from BSA-based systems cannot be directly extrapolated to HSA behavior or performance. It is important to note that during thermally induced gelation, both BSA and HSA form gels within the temperature range of 70 °C to 100 °C [21,22,23], which exceeds their denaturation thresholds. This, in turn, leads to several critical issues: impairment of albumin’s binding sites for therapeutic agents, hydrogel opacity, and reduced cell proliferation on the hydrogel surface, among others [20]. In addition to temperature and protein concentration, various chemical agents significantly influence the albumin gelation process. For instance, urea [24] and surfactants [25] substantially reduce the gelation temperature and time for BSA by promoting protein unfolding and disrupting hydrophobic interactions. Furthermore, several studies have reported the formation of BSA-based hydrogels induced by ethanol at a temperature of 37 °C [26,27]. Moreover, it has been demonstrated that small quantities of ethanol can reduce the gelation temperature of BSA below 59 °C [28]. However, to the best of the authors’ knowledge, no studies have been conducted to date on the influence of ethyl alcohol on the thermally induced formation of HSA-based hydrogels. Thus, the present study will fabricate human serum albumin-based hydrogels via thermal gelation with ethanol addition, which represent promising materials for developing advanced hydrogel wound dressings.

2. Results and Discussion

2.1. Effect of Synthesis Conditions on Human Serum Albumin-Based Hydrogel Formation

Despite extensive research on serum albumin (both bovine and human) as a drug-delivery vehicle [29,30,31], its application in hydrogel-based biomedical systems has only recently emerged. Consequently, the mechanisms governing albumin hydrogel formation remain inadequately characterized. Nevertheless, interest in these materials is growing due to their biocompatibility, bioinertness, and capacity for gelation across a broad concentration range, making them suitable for tissue engineering and regenerative medicine [32,33]. Thermally induced gelation is a versatile and practical method for fabricating albumin-based hydrogels [20]. In terms of structure, this process occurs via two sequential stages: first, thermal denaturation unfolds albumin’s polypeptide chains, disrupting its tertiary structure [34]; second, progressive heating reduces α-helical content while promoting intra- and intermolecular β-sheet formation, which constitutes the three-dimensional hydrogel scaffold [35]. Thus, thermal gelation enables rapid, straightforward fabrication of stable hydrogels without toxic chemical cross-linkers [19].
In the initial series of experiments, human serum albumin (HSA) hydrogels were fabricated via thermally induced gelation of aqueous HSA solutions. Hydrogel samples with HSA concentrations of 10–20% (w/v) were synthesized in an aqueous medium at 60–80 °C with a 10-minute incubation period. Data presented in Table 1 and Figure 1 demonstrate that hydrogels containing 20% (w/v) HSA exhibit incomplete gelation at 70 °C. At temperatures ≥ 75 °C, turbidity develops due to albumin denaturation. According to established literature, thermal protein denaturation follows the Eyring-Lumry model [36,37] (Figure 2), wherein the first stage entails reversible conformational changes [38], while the second stage involves irreversible structural alterations. For HSA, such irreversible changes occur predominantly at temperatures exceeding 74 °C [38,39]. Consequently, gelation above 74 °C leads to substantial loss of optical transparency in the resultanthydrogels, attributable to extensive irreversible denaturation of albumin molecules. Optical transparency is critical for wound-healing hydrogels, as it permits visual monitoring of wound progression without frequent dressing removal—a procedure that causes significant patient distress. Additionally, albumin denaturation compromises drug-binding sites, thereby limiting the utility of albumin-based scaffolds in advanced drug delivery applications [40].
In the preparation of albumin-based hydrogels, ethanol is commonly utilized to induce the denaturation and subsequent gelation of HSA [9]. Although the precise mechanisms by which ethanol modulates serum albumin structure remain debated, prevailing theory posits that this less polar solvent disrupts hydrophobic interactions within the protein, promoting interchain hydrogen bonding and a conformational shift toward β-sheet-rich extended structures [41]. Prior investigations of ethanol-mediated gelation have focused exclusively on BSA in aqueous-ethanol systems, demonstrating that gelation occurs below BSA’s thermal denaturation temperature following ethanol addition [26]. Notably, the influence of ethanol on the structural and gelation properties of HSA-hydrogels remains unexplored in the literature.
Analysis of circular dichroism (CD) spectra revealed that ethanol addition altered the secondary structure of human serum albumin (HSA), characterized by reduced amplitude of negative bands at 208 nm and 222 nm—indicative of partial α-helix loss (Figure 3). Quantitative deconvolution (Table 2) confirmed a decrease in α-helical content from 61.1% ± 0.9% to 54.3% ± 0.8%, accompanied by a concomitant increase in β-sheet content from 3.2% ± 0.1% to 5.6% ± 0.2%. These changes reflect partial, reversible reorganization of HSA’s secondary structure in ethanol-water mixtures, while retaining key native spectral features. Critically, under these conditions (≤50% ethanol), the protein maintains partial native conformation, consistent with literature demonstrating that globular proteins retain ~50% α-helical structure at 40–50% ethanol. Irreversible denaturation and aggregation dominate only at higher ethanol concentrations (≥60–70%) [42]. Thus, 50% ethanol represents an optimal compromise for HSA hydrogel fabrication, enabling sufficient structural modification for gelation while preserving the native conformation essential for functional applications.
Hydrogel samples containing 10% (w/v) human serum albumin (HSA) in aqueous medium were synthesized at 50–55 °C with a 10-minute incubation period, incorporating varying ethanol volume fractions (Figure 4 a,b). Ethanol addition markedly reduced the HSA gelation temperature—from 80 °C to 55 °C for 10% (w/v) protein—yet yielded hydrogels with poor mechanical stability. Over time, these samples exhibited phase separation and precipitation of denatured HSA. Consequently, these findings demonstrate that buffered aqueous solutions of defined ionic strength and pH are necessary for stable HSA-hydrogels with preserved native protein structure.
Subsequent experiments on the formation of human serum albumin-based hydrogels were conducted using phosphate-buffered saline and ethanol with a volume fraction not exceeding 20% (v/v) in the mixture. The choice of buffer was motivated by the fact that phosphate-buffered saline is approved for medical applications, while the ethanol volume fraction was limited based on the following considerations. The study [43] demonstrated that the process of conformational changes in the HSA structure under the influence of ethanol is non-linear: free water molecules or weakly hydrogen-bonded water molecules predominate at low ethanol concentrations (20% v/v), whereas the hydration layer transforms into a strongly hydrogen-bonded water cluster as the ethanol concentration increases. These water clusters play a substantial role in linking individual protein molecules, which may be necessary for nucleation and protein precipitation, while excessive ethanol addition can disrupt the HSA structure. Therefore, to preserve the protein structure as close as possible to its native state, the volume fraction of ethanol in the hydrogel was maintained at or below 20% (v/v). The data presented in Figure 5 and Table 3 demonstrate that the combination of PBS and ethanol allowed hydrogels with both optical transparency and mechanical stability to develop. The authors identified the following compositions as optimal: 10% HSA–20% EtOH and 15% HSA–20% EtOH for gelation at 55 °C with a 10-minute incubation; 10% HSA–15% EtOH and 15% HSA–15% EtOH for gelation at 60 °C with a 10-minute incubation.
The influence of incubation time on the formation of HSA-based hydrogels was investigated. For HSA-PBS-ethanol systems that did not form a hydrogel within 10 minutes, the incubation time was extended to 30 and 60 minutes at their respective temperatures. For samples forming a hydrogel with substantial denaturation within 10 minutes, the incubation time was reduced to 1 and 5 minutes. It was demonstrated that extending the heating time for hydrogels previously unformed within 10 minutes resulted in successful gelation only at 20% ethanol volume fraction in the mixture (Table 4). Conversely, reducing the heating time for hydrogels exhibiting substantial denaturation after a 10-minute incubation proved to be an effective approach, except for mixtures with a 20% ethanol volume fraction (Table 5).
Screening experiments on the lyophilization of human serum albumin-based hydrogels were conducted. Freeze-drying is a versatile technique for producing porous hydrogel matrices, which have recently attracted growing interest in tissue engineering. Moreover, the lyophilization of hydrogels can significantly extend their shelf life, particularly when they are loaded with various therapeutic agents. It was demonstrated that during the lyophilization of human serum albumin-based hydrogels with water, the freeze-drying process produced a powder (Figure 6). This powder could be resuspended into a solution upon the addition of water. In contrast, hydrogels based on HSA and PBS were lyophilized into a single, pellet-like structure. When water was added to this structure, it re-suspended and re-formed a hydrogel. Thus, the developed approach for fabricating human serum albumin-based hydrogels opens up broad prospects for the further investigation of porous hydrogel scaffolds derived from them.
Scanning electron microscopy (SEM) was employed to analyze the morphology of lyophilized scaffolds prepared from hydrogels of three compositions: 15 HSA – 15 EtOH, 20 HSA – 15 EtOH, and 15 HSA – 10 EtOH. For the 15 HSA – 15 EtOH composition (Figure 7a,b), a porous structure with irregularly shaped pores ranging from several to tens of micrometers in size is observed. Well-defined boundaries between material fragments indicate spatial heterogeneity in polymer network density — reflecting regions with varying degrees of packing. At higher magnification, thin, interwoven fibrillar elements are revealed, forming an open, highly interconnected porous network. Some areas exhibit increased density, while others display pronounced inter-fibrillar porosity, confirming the multi-scale, sponge-like nature of the scaffold architecture. Scaffolds of the 20 HSA – 15 EtOH composition (Figure 7 c, d) exhibit a distinct layered, oriented microstructure. Numerous oval- and slit-shaped pores (1–10 µm in size) are present between the layers. Despite a degree of ordering, the structure remains irregular, suggesting spontaneous self-organization of the protein network during gelation. The 15 HSA – 10 EtOH scaffold (Figure 7 e, f) displays a hierarchical porous morphology: at the macro-scale, fragmented domains with a “foamy” texture and visible cracks indicate dehydration-induced shrinkage and brittleness in the dry state. At higher magnification, an open, percolating pore network emerges, composed of irregularly shaped pores (from rounded to slit-like), bounded by thin walls (1–5 µm thick) with granular surface texture — indicative of secondary microstructure and composite nature, combining dense, scaffold-like regions with more loosely packed, spongy zones. Collectively, SEM analysis reveals a clear compositional dependence of scaffold morphology: a decrease in HSA mass fraction and an increase in ethanol volume fraction in the precursor solution lead to enhanced porosity and the development of a more open, less densely packed fibrous architecture.

2.2. Investigation of Hydrogel Gelation Kinetics via Dynamic Light Scattering (DLS)

To determine the influence of ethanol and the aqueous environment on the gelation kinetics of human serum albumin (HSA)-based hydrogels, in situ hydrogel formation tests were conducted with simultaneous monitoring by dynamic light scattering (DLS). Although the microstructure and mechanical properties of protein- and peptide-based hydrogels have been extensively characterized using techniques such as rheometry and transmission electron microscopy, the kinetics of aggregation and subsequent gelation have received significantly less attention [45]. Hydrogel formation proceeds through the following stages: (1) Initial homogeneous solution; (2) Aggregation of colloidal particles into clusters; (3) Cluster growth; (4) Percolation and hydrogel network formation; (5) Development of a macrogel network [46]. DLS enables real-time observation of all these stages during hydrogel formation, allowing determination of the percolation time and average cluster size.
In situ formation of HSA-based hydrogels was performed in a DLS cuvette with simultaneous monitoring. The visual appearance of hydrogels formed in the cuvette, as a function of ethanol volume fraction, is shown in Figure 6a. When HSA was dissolved in water, hydrogel formation occurred exclusively in the absence of ethanol; even 5% (v/v) ethanol induced gelation. Post-gelation, the average hydrodynamic diameter exceeded 1000 nm (Table 6). In contrast, when HSA was diluted in phosphate-buffered saline (PBS), hydrogel formation required a higher ethanol volume fraction (≥15%). Under these conditions, the average hydrodynamic diameter after gelation was substantially smaller (400–500 nm). These results demonstrate that stabilization of ionic strength and pH is essential for forming sedimentation-resistant hydrogels during thermally induced gelation. PBS addition reduced the average aggregate size of HSA, yielding stable, optically transparent hydrogels.
It is important to note the limitations of DLS for the hydrogel systems investigated here. The upper size detection limit is constrained by sedimentation onset [47]. For aqueous-based hydrogels, kinetic curves exhibited classical sigmoidal profiles (Figure 8). In PBS-based systems, significant fluctuations in hydrodynamic radius occurred post-gelation (Figure 6c) due to contributions from depolarized light scattering by clusters/percolation networks and multiple light scattering effects [48]. Consequently, aqueous-based hydrogels—with limited 3D network robustness and high sedimentation susceptibility—were detected primarily as microparticles. For strongly cross-linked PBS-based hydrogels, multiple scattering introduced substantial errors in mean cluster size and cross-linking density determinations. Nevertheless, despite significant error margins in absolute values during kinetic profiling, this in situ method enables qualitative and semi-quantitative assessment of thermally induced protein hydrogel formation mechanisms.

2.3. Investigation of Rheological Properties of HSA-Based Hydrogels

The rheological properties of HSA-based hydrogels were systematically investigated to evaluate their suitability for biomedical applications, including injectable drug delivery and tissue engineering. Dynamic viscosity was assessed at shear rates of 3, 15, and 45 s⁻¹ (Table 7). Most hydrogels exhibit non-Newtonian pseudoplastic behavior (shear-thinning), which is characteristic of thixotropic systems [44]. This property is critical for applications requiring injectability, controlled drug delivery, or bioprinting in tissue engineering. The rheological properties of human serum albumin-based hydrogels, namely flow behavior, dynamic viscosity, and thixotropy, were investigated in relation to the hydrogel synthesis conditions.
Based on dynamic viscosity measurements, the hydrogels were grouped into four distinct categories (Table 8):
  • Group 1 (viscosity: 100–1000 mPa·s at 3 s⁻¹) includes formulations with lower HSA and ethanol concentrations (e.g., 10% HSA with 10–15% EtOH, incubated 30–60 min). These systems demonstrate low resistance to flow and are perfect candidates for minimally invasive delivery, aligning with viscosity thresholds reported for injectable hydrogels in the literature [45,46].
  • Group 2 (1000–5000 mPa·s at 3 s⁻¹) encompasses moderately crosslinked systems, such as 15% HSA with 10–15% EtOH or 20% HSA with 10–15% EtOH (short incubation times). These hydrogels retain injectability while offering enhanced mechanical stability post-injection, making them suitable for sustained release applications.
  • Group 3 (5000–10,000 mPa·s at 3 s⁻¹) includes formulations with higher protein content and intermediate ethanol concentrations (e.g., 15–20% HSA with 15–20% EtOH, 5–10 min incubation). Their elevated viscosity suggests potential use as structural scaffolds or depot-forming carriers for prolonged therapeutic action, though injection may require larger-bore needles or pre-warming to reduce viscosity.
  • Group 4 (10,000–25,000 mPa·s at 3 s⁻¹) comprises systems with high ethanol content (20% EtOH) and moderate HSA concentrations (10–15%). Notably, while some samples in this group exhibited extremely high viscosities (e.g., 10 HSA–20 EtOH at 10 min: ~32,070 mPa·s at 5 s⁻¹), others (e.g., 15 HSA–20 EtOH at 10 min) became unmeasurable, likely due to excessive protein denaturation and rapid gelation, leading to solid-like behavior that exceeds the rheometer’s detection range. This highlights the narrow formulation window for ethanol-induced HSA gelation: while ethanol promotes crosslinking via partial denaturation, excessive concentrations or prolonged exposure disrupt network homogeneity, resulting in brittle or non-processable gels.
The thermally induced gelation method supplemented with ethanol as an additional denaturing agent offers a key advantage: it enables the production of stable hydrogels across a wide viscosity range (100–10,000 mPa·s). This versatility allows for the development of universal platforms—from relatively fluid formulations suitable for topical application on superficial wounds to highly viscous hydrogels for forming therapeutic coatings in deep tissue injuries. In conclusion, the proposed approach to forming HSA hydrogels combines simplicity, high reproducibility, and flexibility in tuning physico-mechanical properties, rendering it a promising strategy for applications in tissue engineering and regenerative medicine.
Figure 9, Figure 10 and Figure 11 present the dynamic viscosity curves of HSA hydrogels (10–20 wt%) across a shear rate range of 1–60 s⁻¹. All formulations exhibited shear-thinning behavior characteristic of physically crosslinked protein-based systems, resulting from the transient disruption of the gel network under shear. At a fixed HSA concentration, increasing ethanol content and incubation time (1–60 min) led to a pronounced rise in viscosity, reflecting accelerated gelation due to partial protein denaturation and intermolecular aggregation. Specifically, for 20% HSA, viscosity at a shear rate of 5 s⁻¹ increased from ~2800 mPa·s (15% EtOH, 1 min) to ~7700 mPa·s (5–10 min), whereas with only 10% EtOH, viscosity remained below ~3900 mPa·s even after 60 min (Figure 9). For 15% HSA, hydrogels formulated with 20% EtOH exhibited a sharp viscosity increase (>23,000 mPa·s within 5 min), and by 10 min the samples transitioned into a solid-like state, rendering rheological measurements unfeasible (Figure 10). In contrast, with 10–15% EtOH, viscosity remained moderate (2500–5200 mPa·s) even after 60 min of incubation. The effect was most pronounced in 10% HSA systems: with 20% EtOH, viscosity rose from ~3700 to >32,000 mPa·s within 10 min, whereas with only 10% EtOH viscosity stayed low (≤600 mPa·s), confirming their suitability for injectable formulations (Figure 11). Collectively, these findings demonstrate that ethanol concentration and incubation time synergistically govern the viscoelastic architecture of HSA-based hydrogels. Higher ethanol content accelerates protein unfolding and promotes intermolecular β-sheet formation, triggering rapid network percolation. Conversely, lower ethanol concentrations or extended incubation times enable more homogeneous and controllable gelation kinetics.
As shown in Table 9, an increase in the ethanol volume fraction in human serum albumin (HSA)-based hydrogels correlates with a rise in their thixotropic index. This behavior is attributed to the formation of additional hydrophobic associations within the polymer network, driven by the tendency of nonpolar groups to minimize contact with the aqueous environment. These associations act as transient crosslinking points, contributing to mechanical energy dissipation [47]. Unlike covalent bonds, hydrophobic interactions are characterized by lability, reversibility, and cooperativity. Under shear stress, these associations break, leading to gel thinning (transition to a sol-like state). Upon removal of stress, thermodynamically favored reassociation of hydrophobic domains enables self-recovery of the network structure. An increased density of hydrophobic associations accelerates the kinetics of reorganization and enhances the strength of the equilibrium network, resulting in a more pronounced thixotropic response.
Conversely, the decrease in the thixotropic index with increasing HSA concentration (Table 9) reflects a structural transition in the hydrogel network: from a dynamic, physically crosslinked system to a more static matrix exhibiting covalent-like characteristics. In diluted systems, gelation is governed by reversible physical interactions—hydrophobic associations, hydrogen bonding, and electrostatic interactions. These interactions possess short relaxation times, allowing the network to break under shear and rapidly recover upon stress removal, which manifests as high thixotropy. The low crosslinking density ensures sufficient chain mobility for efficient restructuring. In concentrated systems, intense intermolecular aggregation leads to the formation of a dense network stabilized by cooperative interactions, primarily associated with fibrillar aggregates. The elevated crosslinking density and steric constraints drastically reduce macromolecular mobility, slowing down the kinetics of bond rupture and reformation—even if the interactions remain physical in nature. Disruption of critical crosslinking points in such networks requires substantial energy due to the high dissociation barrier of cooperative aggregates. Consequently, higher shear stress is needed to induce gel thinning, and structural recovery after stress removal may be incomplete or significantly delayed.

2.4. Investigation of the Rheological and Antibacterial Properties of Tetracycline-Loaded HSA-Based Hydrogels

To demonstrate the potential of HSA-based hydrogels for the controlled release of low molecular weight therapeutic drugs, a study was conducted on the kinetics of tetracycline release, a broad-spectrum antibiotic. The antibiotic was loaded into the hydrogel at the gelation stage, and its final concentration was 1.5 mg/ml. The aforementioned assumption regarding the correlation between tetracycline release efficiency and the structural properties of the hydrogel is confirmed by a further experiment that examined the kinetics of tetracycline release from HSA-based hydrogels with varying HSA/EtOH ratios (Figure 12). As previously discussed, all HSA-based hydrogels exhibited a characteristic release pattern. Within the first hour, a rapid release was observed, the magnitude of which was dependent on the HSA/EtOH ratio: 15/15 HSA/EtOH ˃ 20/15 HSA/EtOH ˃ 15/10 HSA/EtOH. During the five-day monitoring period, the total amount of tetracycline released followed the same rank order. Consequently, an increase in the EtOH proportion during hydrogel preparation (i.e., a decrease in the HSA/EtOH ratio) resulted in accelerated and more substantial drug release, which is associated with the size of the pores formed in the hydrogel. According to the data obtained via scanning electron microscopy, an increase in the amount of denaturing agent, i.e., EtOH, results in a decrease in the size of the pores in the hydrogel. This, in turn, affects the rate of drug release. The findings indicate that the HSA/EtOH ratio is a critical formulation parameter governing both the intensity of the initial release and the overall extent of tetracycline release from HSA-based hydrogels.
The efficiency of tetracycline release was studied in two media (phosphate-buffered saline (PBS) and 10% fetal bovine serum (FBS)) under different modes of medium replacement over the hydrogel (15 HSA – 15 EtOH) surface (gradual and complete). The gradual replacement mode simulated partial fluid renewal (slow exchange, close to physiological), and the complete replacement mode simulated intensive washout. Figure 13 presents the antibiotic release curves in two different media: PBS (Figure 13a) and FBS (Figure 13b). The data points on the graphs represent the total amount of the substance (µg/ml) released from the hydrogel at the corresponding time point. Tetracycline release profile from HSA-based hydrogels exhibited two phases under all tested conditions, characterized by an initial rapid release during the first hour followed by a more gradual sustained release. Across both replacement modes, the final level of antibiotic release was found to be slightly higher in 10% FBS compared to PBS. This phenomenon is likely to be a consequence of the presence of proteins in FBS, which have the capacity to either bind to tetracycline, thereby improving its solubilization, or to enhance hydrogel disassembly. The mode of medium replacement exerted a negligible influence on the release kinetics in both PBS and 10% FBS. On the first day, the gradual replacement in the medium resulted in a slightly faster increase in tetracycline amount. However, these differences were subsequently leveled off at later time points. The findings suggest that tetracycline release is primarily governed by the internal diffusion and structural properties of the hydrogel, with medium composition exerting a stronger effect than the medium replacement mode. These findings emphasize the potential of human serum albumin-based hydrogel systems in the controlled release of tetracycline, with the capability to be adapted to a range of therapeutic requirements.
Following a five-day incubation period at 37 °C, with gentle stirring at a rate of 300 rpm, human serum albumin-based hydrogels exhibited notable variations in appearance, depending on the medium used (Figure 14). In PBS, the hydrogels largely retained their structural integrity, remaining relatively transparent and compact, indicating good structural stability and resistance to swelling or disintegration. Slight turbidity of the surrounding solution and negligible color changes are indicative of the release of tetracycline and minimal erosion of the gel matrix surface. Conversely, in the FBS, the hydrogels exhibited a more pronounced change in color to yellow and demonstrated an increase in softness. This phenomenon can be attributed to the interaction between serum proteins and the albumin network, which may result in a modest weakening of the hydrogel structure and partial binding of tetracycline to serum components. This behavior in a protein-rich environment may be a significant advantage, as it allows for natural biodegradation of the material without the need for mechanical removal, which is particularly beneficial for localized therapeutic applications. It can thus be concluded that HSA-based hydrogels have the potential to be considered as promising biocompatible systems for the prolonged release of antibiotics, combining structural stability in buffer conditions with gradual biological degradation in conditions close to physiological ones.
To investigate the influence of the nature of bioactive compounds on the rheological properties of HSA-based hydrogels, the dynamic viscosity of a 15% w/v HSA–15% v/v EtOH hydrogel with different antibacterial agents was measured (Figure 15). As antibacterial therapeutic agents, methylene blue and tetracycline were selected due to their significantly different chemical natures. Methylene blue is a highly hydrophilic compound with high water solubility [48], whereas tetracycline, despite its hydrophilic molecular structure, forms an intramolecular zwitterion salt that exhibits very low polarity and, consequently, poor solubility in polar solvents [49]. As shown in Figure A, the dynamic viscosity curves reveal no statistically significant differences between HSA hydrogels loaded with either methylene blue or tetracycline and the “blank” HSA hydrogel. These findings suggest that the hydrogel formulation presented in this study—comprising two solvents, a strongly polar one (water) and an amphiphilic one (ethanol)—enables incorporation of both hydrophilic bioactive agents (dissolved in water) and more hydrophobic compounds (dissolved in ethanol), thus broadening its potential applications.
The antibacterial activity of human serum albumin (HSA)-based hydrogels loaded with tetracycline (0.15 mg/mL) was evaluated against three clinical Staphylococcus aureus strains (SA10177, SA10179, and SA10398) isolated from wound surfaces of diverse etiologies. All tested formulations—20 HSA – 15 EtOH (10 min), 15 HSA – 15 EtOH (10 min), and 15 HSA – 10 EtOH (30 min)—produced distinct inhibition zones, confirming effective antibiotic delivery (Figure 16). In contrast, HSA hydrogels without tetracycline showed no inhibition of bacterial growth, ruling out any intrinsic antibacterial activity of the HSA matrix itself. Quantitative analysis of inhibition zone areas revealed a pronounced dependence of antibacterial efficacy on hydrogel composition (Table). The 15 HSA – 15 EtOH (10 min) formulation exhibited the highest activity, outperforming both the denser 20 HSA – 15 EtOH (10 min) and 15 HSA – 10 EtOH (30 min). The reduced efficacy of 20 HSA – 15 EtOH (10 min) correlates with scanning electron microscopy data indicating a denser, less porous network that likely restricts tetracycline diffusion from the matrix. Conversely, the slightly smaller inhibition zones observed for 15 HSA – 10 EtOH (30 min) suggest a more rapid initial release of the antibiotic from its less viscous and highly porous structure, potentially leading to faster depletion of tetracycline from the effective zone. Thus, the 15 HSA – 15 EtOH (10 min) composition achieves an optimal balance between matrix density and porosity, enabling sustained tetracycline release and maximizing short-term antibacterial efficacy.
Table 10. Inhibition zone areas (cm²) against S. aureus strains induced by HSA-based hydrogels loaded with tetracycline (0.15 mg/mL).
Table 10. Inhibition zone areas (cm²) against S. aureus strains induced by HSA-based hydrogels loaded with tetracycline (0.15 mg/mL).
SA10177 SA10179 SA10398
Inhibition zone area (cm²)
20 HSA – 15 EtOH – 10 min 3,38±0,10 2,57±0,05 2,87±0,06
15 HSA – 15 EtOH – 10 min 4,36±0,16 2,93±0,18 3,15±0,08
15 HSA – 10 EtOH – 30 min 3,90±0,06 2,66±0,10 2,83±0,39

3. Conclusions

In this study, a method for preparing human serum albumin-based hydrogels via thermally induced gelation was developed. It was found that aqueous HSA hydrogels form at temperatures significantly above the denaturation temperature of human serum albumin, while the addition of ethanol significantly reduces the gelation temperature. It was demonstrated that the combination of phosphate-buffered saline (PBS) as an albumin solvent and ethyl alcohol enables the formation of hydrogels exhibiting optical transparency and mechanical stability. In the PBS-HSA-EtOH system, the ideal compositions for hydrogel formation are 10% HSA – 20% EtOH and 15% HSA – 20% EtOH at 55 °C with a 10-minute incubation time; 10% HSA – 15% EtOH and 15% HSA – 15% EtOH at 60 °C with a 10-minute incubation time. Dynamic light scattering (DLS) revealed that hydrogel formation in aqueous HSA solutions results in significantly larger albumin aggregates (Z-average = 1500–8500 nm) compared to hydrogels based on HSA solutions in PBS (Z-average = 450–500 nm). It was demonstrated that hydrogels prepared via thermally induced gelation with a denaturing agent (ethyl alcohol) exhibit dynamic viscosity in the range of 100–10000 mPa·s. The release kinetics of tetracycline from human serum albumin-based hydrogels were investigated in two media - PBS and FBS. The hydrogels exhibited differential behavior in the studied media: they maintained structural integrity in PBS, while softening and color changes were observed in FBS, indicating biodegradation under near-physiological conditions. All tested formulations of human serum albumin (HSA)-based hydrogels loaded with tetracycline (0.15 mg/mL) was demonstrated antibacterial activity of against three clinical Staphylococcus aureus strains (SA10177, SA10179, and SA10398) isolated from wound surfaces of diverse etiologies. The resultant human serum albumin-based hydrogels represent promising platforms for developing topical formulations for wound healing and tissue engineering applications.

4. Materials and Methods

4.1. Materials

Lyophilized human serum albumin (REANHAL, Hungary) was used without further purification. Ethanol (EtOH) (Kemerovo Pharmaceutical Factory, Russia) underwent rectification-based dehydration under laboratory conditions to obtain the absolute product. Type 1 water was purified using a Milli-Q water purification system (Merck Millipore, Germany). Tablet-form Dulbecco’s phosphate-buffered saline (PBS) was supplied by Sigma-Aldrich, USA, fetal bovine serum (FBS) (Gibco, Waltham, MA, USA), tetracycline hydrochloride (Gerbu biotechnik, Germany).

4.2. Synthesis of Hydrogels Based on Human Serum Albumin

Synthesis of HSA hydrogels was carried out by thermally induced gelation. For the formation of HSA hydrogels, human serum albumin was dissolved in deionized water or Dulbecco’s phosphate-buffered saline to obtain solutions with a mass fraction of 10-20%. After complete dissolution of HSA, a required volume of ethanol was added to the solution. The gel was subsequently formed from the resulting solution via static heating. The formation of HSA-based hydrogels was visually assessed using the vial inversion method.

4.3. In situ Study of Gelation in HSA-Based Aqueous-Ethanol Systems

Measurements of gelation onset time and mean aggregate size during gelation were performed using dynamic light scattering (DLS) on a Zetasizer Nano ZC particle size and zeta potential analyzer (Malvern Instruments, UK). Gelation measurements were conducted in a ZEN0040 cuvette with a lid, with an added liquid volume of 500 μl. For each sample, 150 measurements were performed in “size” mode, with a 0-second delay between measurements, 5 runs per measurement, and a run duration of 5 seconds. Gelation measurements were initiated only after reaching the gelation temperature (60 °C).

4.4. Measurement of Dynamic Viscosity of HSA-Based Hydrogels

In this study, the dynamic viscosity was measured using a DV3T-RV viscometer (Brookfield Engineering Labs, USA) with a cone/plate geometry at 25 °C, utilizing the RheocalcT software package. Depending on the paste viscosity, CPE-40 and CPE-52 spindles were employed during measurements.

4.5. Lyophilization of HSA-Based Hydrogels

Lyophilization of hydrogels was performed using a BK-FD10S freeze dryer (Biobase, China). The temperature of the cooling condenser in the dryer was set at -60 °C. The samples were cooled in the condenser to -25 °C and subsequently subjected to vacuum drying. After initiating the vacuum, the samples were heated to 0 °C over a period of 20 minutes and then dried to room temperature for 10 hours. The product temperature was calculated based on the reading from a temperature probe.

4.6. Study of Lyophilizated HSA-Based Hydrogels Microstructure

The microstructure of the samples surface was studied by scanning electron microscopy (SEM). The samples were fixed on a sample holder using double-sided carbon tape, coated with 10 nm gold/palladium layer and analyzed using an EVO 10 scanning electron microscope (Carl Zeiss AG, Oberkochen, Germany) at an accelerating voltage of 10 kV

4.7. Synthesis of Human Serum Albumin-Based Hydrogels with Tetracycline

The synthesis of hydrogels based on human serum albumin (HSA) containing tetracycline was carried out using the thermally induced gelation method. The HSA protein was dissolved in PBS to obtain a solution with a mass fraction of 15%. Following the complete dissolution of the albumin, the requisite volume of tetracycline solution in ethanol (1 mg/ml) was introduced into the system to achieve an ethanol volume fraction of 15%. The mixture was stirred until a homogeneous solution was obtained, ensuring uniform distribution of tetracycline throughout the volume. The resulting solution was then subjected to static heating at 60 °C for 10 min in order to form an HSA–tetracycline hydrogel. The assessment of gel formation and integrity was conducted through the utilization of the vial inversion method. The incorporation of tetracycline into the hydrogel structure was observed by the change in color of the sample.

4.8. Determination of the Secondary Structures Content in HSA Molecule by Circular Dichroism

Circular dichroism spectra were recorded using a J-600 spectropolarimeter (Jasco, Japan) at room temperature in the wavelength range corresponding to the far UV region (λ = 190–240 nm) in a quartz cuvette with an optical path length of 0.01 cm. The volume of the studied sample was 120 μL, the protein concentration in the sample was 1.5 × 10–5 M. For each spectrum, ten spectra were accumulated at a scanning speed of 50 nm/min. The obtained spectra were processed by extrapolation from theoretical spectra, and the percentage of secondary structures in the protein molecule was found from the obtained data.

4.9. Study of the Kinetics of Tetracycline Release from Hydrogels Based on Human Serum Albumin

The release of tetracycline from the HSA-hydrogel was conducted at 37 °C, with constant stirring at a speed of 300 rpm. For the experiment, a hydrogel containing a known amount of tetracycline was utilized, to which 1 ml of PBS or 10% FBS was added. Two approaches were used to evaluate the effect of the medium replacement mode:
  • Gradual medium replacement: after adding 1 ml of PBS/FBS to the hydrogel, 100 µl of supernatant was removed from the solution at specified time points and replaced with an equal volume of fresh PBS/FBS.
  • Complete medium replacement: the procedure was similar, but 900 µl of supernatant was collected and replaced with an equal volume of fresh PBS/FBS. Samples were collected at the following time points: 0 min, 5 min, 10 min, 15 min, 30 min, 45 min, 60 min, 120 min, 180 min, 240 min, 360 min, 24 h, 48 h and 120 h.
The samples were analyzed for tetracycline content using a spectrophotometric method at room temperature, with an absorption wavelength of λabs = 370 nm. The result was recorded as the absorption value at the end point.

4.10. Antibacterial Activity of Tetracycline-Loaded Hydrogels Based on Human Serum Albumin

Bacterial strains used for evaluating antibacterial activity were kindly provided by the Center for Collective Use “Collection of Extremophilic Microorganisms and Type Cultures” Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (Novosibirsk, Russia). Three tetracycline-susceptible strains of Staphylococcus aureus — SA10177, SA10179, and SA10398 — were employed in this study. All strains are nosocomial isolates derived from wounds of diverse etiologies. The antibacterial activity of human serum albumin based hydrogels was assessed using the agar diffusion method. Sterile Petri dishes were prepared with a bottom layer of nutrient agar (microbial culture broth, LLC “Microgen,” Russia), followed by a top layer of LB agar (Servicebio, China) inoculated with a standardized suspension of S. aureus (~10⁶ CFU/mL). Approximately 70 µL of hydrogel loaded with tetracycline (0.15 mg/mL) was carefully applied onto the surface of the agar. Hydrogels without tetracycline served as negative controls. All plates were incubated at 37 °C for 18–24 hours in a controlled-temperature incubator. The antibacterial effect was evaluated by measuring the diameter and area of the growth inhibition zone surrounding each hydrogel deposit. The inhibition zone area was quantified using ImageJ software (version 1.53t, National Institutes of Health, USA) based on standardized digital images captured under uniform lighting conditions.

Author Contributions

Conceptualization – E.V.D.; Data curation – I.A.Z., I.A.B., E.A.K., Z.K.N.; Methodology – I.A.Z., Investigation – I.A.Z., I.A.B., E.A.K., Z.K.N.; Validation – I.A.Z., I.A.B., E.V.D.; Writing – original draft – I.A.Z., I.A.B.; Writing – review & editing – E.V.D.; Supervision – E.V.D.; Project administration – E.V.D.

Funding

The hydrogel synthesis and its properties investigation were supported by the Russian Science Foundation (No. 25-64-00030). The study of tetracycline loading into human serum albumin-based hydrogels and its release from them were supported by the Russian state-funded project for ICBFM SB RAS (grant number 125012300656−5).

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
HSA human serum albumin
BSA bovine serum albumin
DLS dynamic light scattering
FBS fetal bovine serum
PBS phosphate-buffered saline

References

  1. Peña, O. A.; Martin, P. Cellular and Molecular Mechanisms of Skin Wound Healing. Nat. Rev. Mol. Cell Biol. 2024, 25 (8), 599–616. [CrossRef]
  2. Shi, S.; Wang, L.; Song, C.; Yao, L.; Xiao, J. Recent Progresses of Collagen Dressings for Chronic Skin Wound Healing. Collagen and leather 2023, 5 (1). [CrossRef]
  3. Gounden, V.; Singh, M. Hydrogels and Wound Healing: Current and Future Prospects. Gels 2024, 10 (1). [CrossRef]
  4. Peng, W.; Li, D.; Dai, K.; Wang, Y.; Song, P.; Li, H.; Tang, P.; Zhang, Z.; Li, Z.; Zhou, Y.; Zhou, C. Recent Progress of Collagen, Chitosan, Alginate and Other Hydrogels in Skin Repair and Wound Dressing Applications. Int. J. Biol. Macromol. 2022, 208 (December 2021), 400–408. [CrossRef]
  5. Mani, M. P.; Mohd Faudzi, A. A.; Ramakrishna, S.; Ismail, A. F.; Jaganathan, S. K.; Tucker, N.; Rathanasamy, R. Sustainable Electrospun Materials with Enhanced Blood Compatibility for Wound Healing Applications—A Mini Review. Curr. Opin. Biomed. Eng. 2023, 27 (November 2022), 100457. [CrossRef]
  6. Yu, P.; Wei, L.; Yang, Z.; Liu, X.; Ma, H.; Zhao, J.; Liu, L.; Wang, L.; Chen, R.; Cheng, Y. Hydrogel Wound Dressings Accelerating Healing Process of Wounds in Movable Parts. Int. J. Mol. Sci. 2024, 25 (12). [CrossRef]
  7. Zubair, M.; Hussain, S.; ur-Rehman, M.; Hussain, A.; Akram, M. E.; Shahzad, S.; Rauf, Z.; Mujahid, M.; Ullah, A. Trends in Protein Derived Materials for Wound Care Applications. Biomater. Sci. 2024, 13 (1), 130–160. [CrossRef]
  8. Kuten Pella, O.; Hornyák, I.; Horváthy, D.; Fodor, E.; Nehrer, S.; Lacza, Z. Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine. Int. J. Mol. Sci. 2022, 23 (18). [CrossRef]
  9. Meng, R.; Zhu, H.; Deng, P.; Li, M.; Ji, Q.; He, H.; Jin, L.; Wang, B. Research Progress on Albumin-Based Hydrogels: Properties, Preparation Methods, Types and Its Application for Antitumor-Drug Delivery and Tissue Engineering. Front. Bioeng. Biotechnol. 2023, 11 (April), 1–17. [CrossRef]
  10. Feng, J.; Wang, F.; Shao, Y.; Jin, A.; Lei, L. Engineered Protein-Based Materials for Tissue Repair: A Review. Int. J. Biol. Macromol. 2025, 303 (January), 140674. [CrossRef]
  11. Naik, K.; Singh, P.; Yadav, M.; Srivastava, S. K.; Tripathi, S.; Ranjan, R.; Dhar, P.; Verma, A. K.; Chaudhary, S.; Parmar, A. S. 3D Printable, Injectable Amyloid-Based Composite Hydrogel of Bovine Serum Albumin and Aloe Vera for Rapid Diabetic Wound Healing. J. Mater. Chem. B 2023, 11 (34), 8142–8158. [CrossRef]
  12. Rohiwal, S. S.; Ellederova, Z.; Tiwari, A. P.; Alqarni, M.; Elazab, S. T.; El-Saber Batiha, G.; Pawar, S. H.; Thorat, N. D. Self-Assembly of Bovine Serum Albumin (BSA)-Dextran Bio-Nanoconjugate: Structural, Antioxidant and: In Vitro Wound Healing Studies. RSC Adv. 2021, 11 (8), 4308–4317. [CrossRef]
  13. Guo, C.; Zeng, Z.; Yu, S.; Huang, J.; Geng, Z.; Pei, D.; Lu, D. Synthesis of Bovine Serum Albumin-Gelatin Composite Adhesive Hydrogels by Physical Crosslinking. J. Polym. Res. 2022, 29 (7), 1–9. [CrossRef]
  14. Bercea, M.; Plugariu, I. A.; Dinu, M. V.; Pelin, I. M.; Lupu, A.; Bele, A.; Gradinaru, V. R. Poly(Vinyl Alcohol)/Bovine Serum Albumin Hybrid Hydrogels with Tunable Mechanical Properties †. Polymers (Basel). 2023, 15 (23). [CrossRef]
  15. Tincu, C. E.; Daraba, O. M.; Jérôme, C.; Popa, M.; Ochiuz, L. Albumin-Based Hydrogel Films Covalently Cross-Linked with Oxidized Gellan with Encapsulated Curcumin for Biomedical Applications. Polymers (Basel). 2024, 16 (12). [CrossRef]
  16. Navarra, G.; Peres, C.; Contardi, M.; Picone, P.; San Biagio, P. L.; Di Carlo, M.; Giacomazza, D.; Militello, V. Heat- and PH-Induced BSA Conformational Changes, Hydrogel Formation and Application as 3D Cell Scaffold. Arch. Biochem. Biophys. 2016, 606, 134–142. [CrossRef]
  17. Xia, T.; Jiang, X.; Deng, L.; Yang, M.; Chen, X. Albumin-Based Dynamic Double Cross-Linked Hydrogel with Self-Healing Property for Antimicrobial Application. Colloids Surfaces B Biointerfaces 2021, 208 (July), 112042. [CrossRef]
  18. Kaspchak, E.; Misugi Kayukawa, C. T.; Meira Silveira, J. L.; Igarashi-Mafra, L.; Mafra, M. R. Interaction of Quillaja Bark Saponin and Bovine Serum Albumin: Effect on Secondary and Tertiary Structure, Gelation and in Vitro Digestibility of the Protein. Lwt 2020, 121 (March 2019), 108970. [CrossRef]
  19. Kong, F.; Mehwish, N.; Lee, B. H. Emerging Albumin Hydrogels as Personalized Biomaterials. Acta Biomater. 2023, 157, 67–90. [CrossRef]
  20. Ong, J.; Zhao, J.; Levy, G. K.; Macdonald, J.; Justin, A. W.; Markaki, A. E. Functionalisation of a Heat-Derived and Bio-Inert Albumin Hydrogel with Extracellular Matrix by Air Plasma Treatment. Sci. Rep. 2020, 10 (1), 1–12. [CrossRef]
  21. Yadav, K.; Das, M.; Mishra, N. K.; Chhabra, A.; Mishra, A.; Srivastava, S.; Sharma, P.; Yadav, S. K.; Parmar, A. S. Tunning Self-Assembled Phases of Bovine Serum Albumin via Hydrothermal Process to Synthesize Novel Functional Hydrogel for Skin Protection against UVB. Nanotechnol. Rev. 2022, 11 (1), 1643–1657. [CrossRef]
  22. Khanna, S.; Singh, A. K.; Behera, S. P.; Gupta, S. Thermoresponsive BSA Hydrogels with Phase Tunability. Mater. Sci. Eng. C 2021, 119 (September 2020), 111590. [CrossRef]
  23. Chen, J.; Ma, X.; Dong, Q.; Song, D.; Hargrove, D.; Vora, S. R.; Ma, A. W. K.; Lu, X.; Lei, Y. Self-Healing of Thermally-Induced, Biocompatible and Biodegradable Protein Hydrogel. RSC Adv. 2016, 6 (61), 56183–56192. [CrossRef]
  24. Nnyigide, O. S.; Oh, Y.; Song, H. Y.; Park, E. K.; Choi, S. H.; Hyun, K. Effect of Urea on Heat-Induced Gelation of Bovine Serum Albumin (BSA) Studied by Rheology and Small Angle Neutron Scattering (SANS). Korea Aust. Rheol. J. 2017, 29 (2), 101–113. [CrossRef]
  25. Nnyigide, O. S.; Hyun, K. Effects of Anionic and Cationic Surfactants on the Rheological Properties and Kinetics of Bovine Serum Albumin Hydrogel. Rheol. Acta 2018, 57 (8–9), 563–573. [CrossRef]
  26. Sanaeifar, N.; Mäder, K.; Hinderberger, D. Macro- and Nanoscale Effect of Ethanol on Bovine Serum Albumin Gelation and Naproxen Release. Int. J. Mol. Sci. 2022, 23 (13). [CrossRef]
  27. Michnik, A.; Drzazga, Z. Effect of Ethanol on the Thermal Stability of Human Serum Albumin. J. Therm. Anal. Calorim. 2007, 88 (2), 449–454. [CrossRef]
  28. Sanaeifar, N.; Mäder, K.; Hinderberger, D. Nanoscopic Characterization of Stearic Acid Release from Bovine Serum Albumin Hydrogels. Macromol. Biosci. 2020, 20 (8). [CrossRef]
  29. Murphy, G.; Brayden, D. J.; Cheung, D. L.; Liew, A.; Fitzgerald, M.; Pandit, A. Albumin-Based Delivery Systems: Recent Advances, Challenges, and Opportunities. J. Control. Release 2025, 380 (January), 375–395. [CrossRef]
  30. Asrorov, A. M.; Mukhamedov, N.; Kayumov, M.; Sh. Yashinov, A.; Wali, A.; Yili, A.; Mirzaakhmedov, S. Y.; Huang, Y. Albumin Is a Reliable Drug-Delivering Molecule: Highlighting Points in Cancer Therapy. Med. Drug Discov. 2024, 22 (February), 100186. [CrossRef]
  31. Qu, N.; Song, K.; Liu, M.; Chen, L.; Lee, R. J.; Teng, L. Albumin Nanoparticle-Based Drug Delivery Systems. 2024, No. July.
  32. Ong, J.; Zhao, J.; Justin, A. W.; Markaki, A. E. Albumin-Based Hydrogels for Regenerative Engineering and Cell Transplantation. Biotechnol. Bioeng. 2019, 116 (12), 3457–3468. [CrossRef]
  33. Shi, C.; Li, S.; Li, C.; Liu, H.; Wang, Z.; Li, Y.; Li, M.; Zhang, X.; Mu, W.; Han, X. Bovine Serum Albumin-Based Hydrogels: Preparation, Properties and Biological Applications. Chem. Eng. J. 2024, 498 (July). [CrossRef]
  34. Navarra, G.; Giacomazza, D.; Leone, M.; Librizzi, F.; Militello, V.; San Biagio, P. L. Thermal Aggregation and Ion-Induced Cold-Gelation of Bovine Serum Albumin. Eur. Biophys. J. 2009, 38 (4), 437–446. [CrossRef]
  35. Wang, S. L.; Lin, S. Y.; Li, M. J.; Wei, Y. S.; Hsieh, T. F. Temperature Effect on the Structural Stability, Similarity, and Reversibility of Human Serum Albumin in Different States. Biophys. Chem. 2005, 114 (2–3), 205–212. [CrossRef]
  36. Galisteo, M. L.; Mateo, P. L.; Sanchez-ruiz, J. M. Kinetic Study on the Irreversible Thermal Denaturation Kinase? Biochemistry 1991, 2061–2066.
  37. Lumry, R.; Eyring, H. Conformation Changes of Proteins. J. Phys. Chem. 1954, 58 (2), 110–120. [CrossRef]
  38. Rezaei-Tavirani, M.; Moghaddamnia, S. H.; Ranjbar, B.; Amani, M.; Marashi, S. A. Conformational Study of Human Serum Albumin in Pre-Denaturation Temperatures by Differential Scanning Calorimetry, Circular Dichroism and UV Spectroscopy. J. Biochem. Mol. Biol. 2006, 39 (5), 530–536. [CrossRef]
  39. Kragh-Hansen, U. Effects of Aliphatic Fatty Acids on the Binding of Phenol Red to Human Serum Albumin. Biochem. J. 1981, 195 (3), 603–613. [CrossRef]
  40. Larsen, M. T.; Kuhlmann, M.; Hvam, M. L.; Howard, K. A. Albumin-Based Drug Delivery: Harnessing Nature to Cure Disease. Mol. Cell. Ther. 2016, 4 (1), 1–12. [CrossRef]
  41. Rosenberg, R. M.; Rogers, D. W.; Haebig, J. E.; Steck, T. L. The Interaction of Serum Albumin with Ethanol. Arch. Biochem. Biophys. 1962, 97 (3), 433–441. [CrossRef]
  42. Su Y. Y. T., J. B. Optical Activity Studies of Drug-Protein Complexes, the Interaction of Acetylsalicylic Acid with Human Serum Albumin and Myeloma Immunoglobulin. Biochem. Pharmacol. 1978, 27 (7), 1043–1047. [CrossRef]
  43. Zhang, H.; Liang, M.; Li, S.; Tian, M.; Wei, X.; Zhao, B.; Wang, H.; Dong, Q.; Zang, H. Study on the Secondary Structure and Hydration Effect of Human Serum Albumin under Acidic PH and Ethanol Perturbation with IR/NIR Spectroscopy. J. Innov. Opt. Health Sci. 2023, 16 (4), 1–15. [CrossRef]
  44. Stojkov, G.; Niyazov, Z.; Picchioni, F.; Bose, R. K. Relationship between Structure and Rheology of Hydrogels for Various Applications. Gels 2021, 7 (4). [CrossRef]
  45. Guo, A.; Cao, Q.; Fang, H.; Tian, H. Recent Advances and Challenges of Injectable Hydrogels in Drug Delivery. J. Control. Release 2025, 385, 114021.
  46. Parvin N., Joo S. W., M. T. K. Injectable Biopolymer-Based Hydrogels : A Next-Generation Platform for Minimally Invasive Therapeutics. Gels 2025, 11 (6), 1–41.
  47. Miquelard-garnier, G.; Demoures, S.; Creton, C.; Hourdet, D.; Polyme, P.; June, R. V; Re, V.; Recei, M.; August, V. Synthesis and Rheological Behavior of New Hydrophobically Modified Hydrogels with Tunable Properties. Macromolecules 2006, 39 (23), 8128.
  48. Khan, I.; Saeed, K.; Zekker, I.; Zhang, B.; Hendi, A. H.; Ahmad, A.; Ahmad, S.; Zada, N.; Ahmad, H.; Shah, L. A.; Shah, T.; Khan, I. Review on Methylene Blue: Its Properties, Uses, Toxicity and Photodegradation. Water 2022, 14 (2), 242.
  49. Rusu, A.; Buta, E. L. The Development of Third-Generation Tetracycline Antibiotics and New Perspectives. Pharmaceutics 2021, 13 (12), 2085.
Figure 1. Photographs of HSA hydrogels in aqueous solution as a function of protein concentration. Red border denotes conditions yielding no gelation; orange border indicates incomplete gelation; yellow border signifies hydrogel formation with substantial HSA denaturation.
Figure 1. Photographs of HSA hydrogels in aqueous solution as a function of protein concentration. Red border denotes conditions yielding no gelation; orange border indicates incomplete gelation; yellow border signifies hydrogel formation with substantial HSA denaturation.
Preprints 189212 g001
Figure 2. Schematic representation of protein hydrogel formation via thermally induced gelation according to the Eyring–Lumry model.
Figure 2. Schematic representation of protein hydrogel formation via thermally induced gelation according to the Eyring–Lumry model.
Preprints 189212 g002
Figure 3. Circular dichroism spectra for HSA in 10 mM PBS and in 10 mM PBS/50% EtOH.
Figure 3. Circular dichroism spectra for HSA in 10 mM PBS and in 10 mM PBS/50% EtOH.
Preprints 189212 g003
Figure 4. Photographs of aqueous-based hydrogels as a function of ethanol volume fraction: (a) hydrogels formed at 55 °C; (b) hydrogels formed at 50 °C. Phase separation is highlighted with red frames, and volume fractions of ethanol are labeled in white font.
Figure 4. Photographs of aqueous-based hydrogels as a function of ethanol volume fraction: (a) hydrogels formed at 55 °C; (b) hydrogels formed at 50 °C. Phase separation is highlighted with red frames, and volume fractions of ethanol are labeled in white font.
Preprints 189212 g004
Figure 5. Photographs of aqueous-based hydrogels as a function of ethanol volume fraction: (a) hydrogels formed at 55 °C with 10% w/v HSA; (b) hydrogels formed at 55 °C with 15% w/v HSA; (c) hydrogels formed at 55 °C with 20% w/v HSA; (d) hydrogels formed at 50 °C with 10% w/v HSA; (e) hydrogels formed at 50 °C with 15% w/v HSA; (f) hydrogels formed at 50 °C with 20% w/v HSA. The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
Figure 5. Photographs of aqueous-based hydrogels as a function of ethanol volume fraction: (a) hydrogels formed at 55 °C with 10% w/v HSA; (b) hydrogels formed at 55 °C with 15% w/v HSA; (c) hydrogels formed at 55 °C with 20% w/v HSA; (d) hydrogels formed at 50 °C with 10% w/v HSA; (e) hydrogels formed at 50 °C with 15% w/v HSA; (f) hydrogels formed at 50 °C with 20% w/v HSA. The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
Preprints 189212 g005
Figure 6. Lyophilization scheme of human serum albumin-based hydrogels and photographs of the resulting cryotextured structures before and after resuspension.
Figure 6. Lyophilization scheme of human serum albumin-based hydrogels and photographs of the resulting cryotextured structures before and after resuspension.
Preprints 189212 g006
Figure 7. SEM micrographs of lyophilized human serum albumin-based scaffolds: (a) 15 HSA – 15 EtOH, ×500; (b) 15 HSA – 15 EtOH, ×1000; (c) 20 HSA – 15 EtOH, ×500; (d) 20 HSA – 15 EtOH, ×1000; (e) 15 HSA – 10 EtOH, ×500; (f) 15 HSA – 10 EtOH, ×1000.
Figure 7. SEM micrographs of lyophilized human serum albumin-based scaffolds: (a) 15 HSA – 15 EtOH, ×500; (b) 15 HSA – 15 EtOH, ×1000; (c) 20 HSA – 15 EtOH, ×500; (d) 20 HSA – 15 EtOH, ×1000; (e) 15 HSA – 10 EtOH, ×500; (f) 15 HSA – 10 EtOH, ×1000.
Preprints 189212 g007
Figure 8. (a) Hydrogels in a DLS cuvette in aqueous solutions with varying ethanol volume fractions (values indicated in white); (b) Gelation kinetics monitored by DLS for 10% (w/v) HSA in 10% (v/v) ethanol/water at 60 °C; (c) Gelation kinetics monitored by DLS for 10% (w/v) HSA in 15% (v/v) ethanol/PBS at 60 °C.
Figure 8. (a) Hydrogels in a DLS cuvette in aqueous solutions with varying ethanol volume fractions (values indicated in white); (b) Gelation kinetics monitored by DLS for 10% (w/v) HSA in 10% (v/v) ethanol/water at 60 °C; (c) Gelation kinetics monitored by DLS for 10% (w/v) HSA in 15% (v/v) ethanol/PBS at 60 °C.
Preprints 189212 g008aPreprints 189212 g008b
Figure 9. Dynamic viscosity curves for hydrogels with 20% w/v HSA: (a) 15% v/v ethanol; (b) 10% v/v ethanol.
Figure 9. Dynamic viscosity curves for hydrogels with 20% w/v HSA: (a) 15% v/v ethanol; (b) 10% v/v ethanol.
Preprints 189212 g009
Figure 10. Dynamic viscosity curves for hydrogels with 15% w/v HSA: (a) 20% v/v ethanol; (b) 15% v/v ethanol; (c) 10% v/v ethanol.
Figure 10. Dynamic viscosity curves for hydrogels with 15% w/v HSA: (a) 20% v/v ethanol; (b) 15% v/v ethanol; (c) 10% v/v ethanol.
Preprints 189212 g010aPreprints 189212 g010b
Figure 11. Dynamic viscosity curves for hydrogels with 15% w/v HSA: (a) 20% v/v ethanol; (b) 15% v/v ethanol; (c) 10% v/v ethanol.
Figure 11. Dynamic viscosity curves for hydrogels with 15% w/v HSA: (a) 20% v/v ethanol; (b) 15% v/v ethanol; (c) 10% v/v ethanol.
Preprints 189212 g011aPreprints 189212 g011b
Figure 12. Release curves of tetracycline from human serum albumin-based hydrogels in PBS depending on HSA/EtOH ratio: 15 HSA – 15 EtOH (blue squares), 20 HSA – 15 EtOH (green rhombus), 15 HSA – 10 EtOH (red circles).
Figure 12. Release curves of tetracycline from human serum albumin-based hydrogels in PBS depending on HSA/EtOH ratio: 15 HSA – 15 EtOH (blue squares), 20 HSA – 15 EtOH (green rhombus), 15 HSA – 10 EtOH (red circles).
Preprints 189212 g012
Figure 13. Release curves of tetracycline from human serum albumin-based hydrogels: (a) in PBS; (b) in FBS.
Figure 13. Release curves of tetracycline from human serum albumin-based hydrogels: (a) in PBS; (b) in FBS.
Preprints 189212 g013
Figure 14. Stability and degradation behavior of HSA-based hydrogels in PBS and FBS: (a) gradual replacement; (b) complete replacement.
Figure 14. Stability and degradation behavior of HSA-based hydrogels in PBS and FBS: (a) gradual replacement; (b) complete replacement.
Preprints 189212 g014
Figure 15. Dynamic viscosity curves for hydrogels composed of 15% w/v HSA–15% v/v EtOH (prepared at 60 °C for 10 min): blue line – blank HSA hydrogel; yellow line – HSA hydrogel loaded with methylene blue; gray line – HSA hydrogel loaded with tetracycline.
Figure 15. Dynamic viscosity curves for hydrogels composed of 15% w/v HSA–15% v/v EtOH (prepared at 60 °C for 10 min): blue line – blank HSA hydrogel; yellow line – HSA hydrogel loaded with methylene blue; gray line – HSA hydrogel loaded with tetracycline.
Preprints 189212 g015
Figure 16. Assessment of the antibacterial activity of HSA-based hydrogels loaded with tetracycline (Top row on each Petri dish: hydrogel 20 HSA – 15 EtOH (10 min); middle row: hydrogel 15 HSA – 15 EtOH (10 min); bottom row: hydrogel 15 HSA – 10 EtOH (30 min)). Panels a, c, e: hydrogels containing tetracycline (0.15 mg/mL) applied onto agar plates inoculated with S. aureus strains SA10177 (a), SA10179 (c), and SA10398 (e); Panels b, d, f: antibiotic-free hydrogels applied on the corresponding strains (negative controls). Inhibition zones are observed only in the presence of tetracycline, confirming the absence of intrinsic antibacterial activity of the HSA matrix.
Figure 16. Assessment of the antibacterial activity of HSA-based hydrogels loaded with tetracycline (Top row on each Petri dish: hydrogel 20 HSA – 15 EtOH (10 min); middle row: hydrogel 15 HSA – 15 EtOH (10 min); bottom row: hydrogel 15 HSA – 10 EtOH (30 min)). Panels a, c, e: hydrogels containing tetracycline (0.15 mg/mL) applied onto agar plates inoculated with S. aureus strains SA10177 (a), SA10179 (c), and SA10398 (e); Panels b, d, f: antibiotic-free hydrogels applied on the corresponding strains (negative controls). Inhibition zones are observed only in the presence of tetracycline, confirming the absence of intrinsic antibacterial activity of the HSA matrix.
Preprints 189212 g016aPreprints 189212 g016b
Table 1. Schematic representation of hydrogel formation as a function of temperature and albumin concentration in aqueous solution. Red denotes conditions yielding no gelation; orange indicates incomplete gelation; yellow signifies hydrogel formation with substantial HSA denaturation.
Table 1. Schematic representation of hydrogel formation as a function of temperature and albumin concentration in aqueous solution. Red denotes conditions yielding no gelation; orange indicates incomplete gelation; yellow signifies hydrogel formation with substantial HSA denaturation.
HSA (v/w) / T (ºС) 60 65 70 75 80
10
15
20
Table 2. This is a table. Tables should be placed in the main text near to the first time they are cited.
Table 2. This is a table. Tables should be placed in the main text near to the first time they are cited.
Sample α-helices β-sheets
HSA (10 mM PBS, pH 7.4) 61.1 ± 0.9 3.2 ± 0.1
HSA (50% EtOH) 54.3 ± 0.8 5.6 ± 0.2
Table 3. Schematic representation of hydrogel formation data as a function of temperature, HSA mass fraction, and ethanol volume fraction. Red cells indicate unformed hydrogel; orange cells correspond to partially formed hydrogel; green cells correspond to formed hydrogel; yellow cells represent hydrogel formed with substantial denaturation of HSA.
Table 3. Schematic representation of hydrogel formation data as a function of temperature, HSA mass fraction, and ethanol volume fraction. Red cells indicate unformed hydrogel; orange cells correspond to partially formed hydrogel; green cells correspond to formed hydrogel; yellow cells represent hydrogel formed with substantial denaturation of HSA.
55 °C 60 °C
HSA (v/w) / EtOH (v/v) 10 15 20 10 15 20
0
5
10
15
20
Table 4. Summary data on hydrogel formation depending on incubation time, HSA mass fraction, and ethanol volume fraction at 60 °C (for 0, 5, and 10% v/v ethanol with incubation times of 10, 30, and 60 minutes). The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
Table 4. Summary data on hydrogel formation depending on incubation time, HSA mass fraction, and ethanol volume fraction at 60 °C (for 0, 5, and 10% v/v ethanol with incubation times of 10, 30, and 60 minutes). The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
10 v/w has 15 v/w has 20 v/w HSA
EtOH (v/v) / t (min) 10 15 20 10 15 20 10 15 20
10
30
60
Table 5. Summary data on hydrogel formation depending on incubation time, HSA mass fraction, and ethanol volume fraction at 60 °C (for 10, 15, and 20% v/v ethanol with incubation times of 1, 5, and 10 minutes). The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
Table 5. Summary data on hydrogel formation depending on incubation time, HSA mass fraction, and ethanol volume fraction at 60 °C (for 10, 15, and 20% v/v ethanol with incubation times of 1, 5, and 10 minutes). The red frame corresponds to unformed hydrogel; the orange frame indicates partially formed hydrogel; the yellow frame represents hydrogel formed with substantial denaturation of HSA; green frames indicate formed hydrogel.
10 v/w has 15 v/w has 20 v/w HSA
EtOH (v/v) / t (min) 10 15 20 10 15 20 10 15 20
1
5
10
Table 6. Summary of hydrogel formation as a function of ethanol volume fraction based on DLS measurements (HSA concentration: 10% w/v; temperature: 60 °C).
Table 6. Summary of hydrogel formation as a function of ethanol volume fraction based on DLS measurements (HSA concentration: 10% w/v; temperature: 60 °C).
PBS Water
Ethanol (v/v, %) Hydrogel formation (Yes/No)) Gelation onset time (s) Average hydrodynamic diameter after gelation (nm) Hydrogel formation (Yes/No)) Gelation onset time (s) Average hydrodynamic diameter after gelation (nm)
0 No - - No - -
5 No - - Yes 420 1435±826
10 No - - Yes 336 5845±3945
15 Yes 2700 443±170 Yes 210 8524±5284
20 Yes 600 405±159 Yes 156 8424±7585
Table 7. Summary of dynamic viscosity values for HSA-based hydrogels at shear rates of 5, 15, and 45 s⁻¹.
Table 7. Summary of dynamic viscosity values for HSA-based hydrogels at shear rates of 5, 15, and 45 s⁻¹.
Hydrogel system Dynamic viscosity at a shear rate of 5 s⁻¹, mPa·s Dynamic viscosity at a shear rate of 15 s⁻¹, mPa·s Dynamic viscosity at a shear rate of 45 s⁻¹, mPa·s
20 HSA – 20 EtOH – 60 ⁰С 1 min – unmeasurable 1 min – unmeasurable 1 min – unmeasurable
5 min – unmeasurable 5 min – unmeasurable 5 min – unmeasurable
10 min – unmeasurable 10 min – unmeasurable 10 мин – unmeasurable
20 HSA – 15 EtOH – 60 ⁰С 1 min – 2818 1 min – 1164 1 min – 732
5 min – 7660 5 min – 2500 5 min – 1129
10 min – 6787 10 min – 2474 10 min – 1191
20 HSA – 10 EtOH – 60 ⁰С 10 min – 25,57 10 min – 15,7 10 min – 12,53
30 min – 2223 30 min – 1072 30 min – 621,8
60 min – 3889 60 min – 1495 60 min – 815,8
15 HSA – 20 EtOH – 60 ⁰С 1 min – 7342 1 min – 2183 1 min – 930,5
5 min – 23290 5 min – 10850 5 min – 4379
10 min – unmeasurable 10 min – unmeasurable 10 min – unmeasurable
15 HSA – 15 EtOH – 60 ⁰С 1 min – 1071 1 min – 398,9 1 min – 288,3
5 min – 3373 5 min – 1244 5 min – 590,9
10 min – 5239 10 min – 1627 10 min – 714,4
15 HSA – 10 EtOH – 60 ⁰С 10 min – 10.25 10 min – 7.85 10 min – 6.54
30 min – 1177 30 min – 413,7 30 min – 257,8
60 min – 2542 60 min – 487,2 60 min – 252,3
10 HSA – 20 EtOH – 60 ⁰C 1 min – 3651 1 min – 1177 1 min – 515,9
5 min – 19760 5 min – 4868 5 min – 2011
10 min – 32070 10 min – 7647 10 min – 3197
10 HSA – 15 EtOH – 60 ⁰C 1 min – 344 1 min – 153,1 1 min – 8,18
5 min – 754,1 5 min – 310,6 5 min – 8,17
10 min – 2024 10 min – 1619 10 min – 24,52
10 HSA – 10 EtOH – 60 ⁰C 10 min – 6,54 10 min – 3,27 10 min – 3,27
30 min – 139 30 min – 57,22 30 min – 31,07
60 min – 605 60 min – 237,1 60 min – 139,5
Table 8. Ranges of dynamic viscosity for human serum albumin-based hydrogels.
Table 8. Ranges of dynamic viscosity for human serum albumin-based hydrogels.
Group Samples included in the group Dynamic viscosity range at 3 s⁻¹ (mPa·s) Dynamic viscosity range at 15 s⁻¹ (mPa·s) Dynamic viscosity range at 45 s⁻¹ (mPa·s)
1 10 HSA – 10 EtOH (30 min, 60 min)
10 HSA – 15 EtOH (10 min, 30 min)
100-1000 50-300 20-150
2 10 HSA – 15 EtOH (10 min)
10 HSA – 20 EtOH
(1 min)
15 HSA – 10 EtOH (30 min, 60 min)
15 HSA – 15 EtOH (1 min, 5 min)
20 HSA – 10 EtOH (30 min, 60 min)
20 HSA – 15 EtOH (1 min)
1000-5000 300-1500 150-300
3 15 HSA – 15 EtOH (10 min)
15 HSA – 20 EtOH (1 min)
20 HSA – 15 EtOH (5 min, 10 min)
5000-10000 1500-2500 300-1200
4 10 HSA – 20 EtOH (5 min)
15 HSA – 20 EtOH (5 min, 10 min)
10000-25000 2500-10000 1200-4500
Table 9. Dynamic viscosity ratios (Thixotropic Index) at different shear rates for HSA-based hydrogels.
Table 9. Dynamic viscosity ratios (Thixotropic Index) at different shear rates for HSA-based hydrogels.
Hydrogel system The ratio of the dynamic viscosities at shear rates of 5 s⁻¹ and 15 s⁻¹ The ratio of the dynamic viscosities at shear rates of 5 s⁻¹ and 45 s⁻¹
20 HSA – 20 EtOH – 60 ⁰С 1 min – unmeasurable 1 min – unmeasurable
5 min – unmeasurable 5 min – unmeasurable
10 min – unmeasurable 10 min – unmeasurable
20 HSA – 15 EtOH – 60 ⁰С 1 min – 2,42 1 min – 3,85
5 min – 3,06 5 min – 6,78
10 min – 2,74 10 min – 5,70
20 HSA – 10 EtOH – 60 ⁰С 10 min – 1,63 10 min – 2,04
30 min – 2,07 30 min – 3,58
60 min – 2,60 60 min – 4,76
15 HSA – 20 EtOH – 60 ⁰С 1 min – 3,36 1 min – 7,89
5 min – 2,15 5 min – 5,32
10 min – unmeasurable 10 min – unmeasurable
15 HSA – 15 EtOH – 60 ⁰С 1 min – 2,68 1 min – 3,71
5 min – 2,71 5 min – 5,71
10 min – 3,22 10 min – 7,33
15 HSA – 10 EtOH – 60 ⁰С 10 min – 1,31 10 min – 1,56
30 min – 2,85 30 min – 4,56
60 min – 5,22 60 min – 10,1
10 HSA – 20 EtOH – 60 ⁰C 1 min – 3,10 1 min – 7,08
5 min – 4,06 5 min – 9,82
10 min – 4,19 10 min – 10,03
10 HSA – 15 EtOH – 60 ⁰C 1 min – 2,25 1 min – 42,5
5 min – 2,43 5 min – 92,3
10 min – 1,25 10 min – 82,5
10 HSA – 10 EtOH – 60 ⁰C 10 min – 2,00 10 min – 2,00
30 min – 2,43 30 min – 4,47
60 min – 2,55 60 min – 4,33
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated